Veronique Miron


Scientist, Keenan Research Centre for Biomedical Science


Dr. Miron is the John David Eaton Chair in Multiple Sclerosis Research at the BARLO Multiple Sclerosis Centre and Keenan Research Centre for Biomedical Science, and Full Professor in the Department of Immunology at The University of Toronto. Her team aims to identify novel treatment strategies for neurological conditions in which there is damage to myelin – the insulation surrounding nerve fibres required for their health and function, including multiple sclerosis, Alzheimer’s disease, cerebral palsy, and normal ageing. The focus of the lab is to harness the regenerative properties of immune cells and inflammation to support myelin health across the lifespan. She has won several prestigious awards such as the Medical Research Council Senior Research Award, Medical Research Council Career Development Award, the London Institute of Medical Sciences Suffrage Science Award, and the European Charcot Foundation Young Investigator Award. She is an avid champion of gender equality in research and has put in place several initiatives to improve equality and diversity practices both locally and internationally.

Recent Publications

  1. Molina-Gonzalez, I, Miron, VE, Antel, JP. Chronic oligodendrocyte injury in central nervous system pathologies. Commun Biol. 2022;5 (1):1274. doi: 10.1038/s42003-022-04248-1. PubMed PMID:36402839 PubMed Central PMC9675815.
  2. Paolicelli, RC, Sierra, A, Stevens, B, Tremblay, ME, Aguzzi, A, Ajami, B et al.. Microglia states and nomenclature: A field at its crossroads. Neuron. 2022;110 (21):3458-3483. doi: 10.1016/j.neuron.2022.10.020. PubMed PMID:36327895 .
  3. Edmondson-Stait, AJ, Shen, X, Adams, MJ, Barbu, MC, Jones, HJ, Miron, VE et al.. Early-life inflammatory markers and subsequent psychotic and depressive episodes between 10 to 28 years of age. Brain Behav Immun Health. 2022;26 :100528. doi: 10.1016/j.bbih.2022.100528. PubMed PMID:36277463 PubMed Central PMC9582583.
  4. Smith, KJ, Minns, D, McHugh, BJ, Holloway, RK, O'Connor, R, Williams, A et al.. The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation. PLoS Biol. 2022;20 (8):e3001554. doi: 10.1371/journal.pbio.3001554. PubMed PMID:36026478 PubMed Central PMC9455863.
  5. Labrak, Y, Heurtault, B, Frisch, B, Saulnier, P, Lepeltier, E, Miron, VE et al.. Impact of anti-PDGFRα antibody surface functionalization on LNC uptake by oligodendrocyte progenitor cells. Int J Pharm. 2022;618 :121623. doi: 10.1016/j.ijpharm.2022.121623. PubMed PMID:35231547 .
  6. Mahmood, A, Miron, VE. Microglia as therapeutic targets for central nervous system remyelination. Curr Opin Pharmacol. 2022;63 :102188. doi: 10.1016/j.coph.2022.102188. PubMed PMID:35219055 .
  7. Amor, S, McNamara, NB, Gerrits, E, Marzin, MC, Kooistra, SM, Miron, VE et al.. White matter microglia heterogeneity in the CNS. Acta Neuropathol. 2022;143 (2):125-141. doi: 10.1007/s00401-021-02389-x. PubMed PMID:34878590 .
  8. Michelucci, A, Miron, VE, Priller, J. Special Issue "Microglia Heterogeneity and Its Relevance for Translational Research". Int J Mol Sci. 2021;22 (22):. doi: 10.3390/ijms222212350. PubMed PMID:34830232 PubMed Central PMC8620786.
  9. Conole, ELS, Stevenson, AJ, Muñoz Maniega, S, Harris, SE, Green, C, Valdés Hernández, MDC et al.. DNA Methylation and Protein Markers of Chronic Inflammation and Their Associations With Brain and Cognitive Aging. Neurology. 2021;97 (23):e2340-e2352. doi: 10.1212/WNL.0000000000012997. PubMed PMID:34789543 PubMed Central PMC8665430.
  10. MacKenzie, G, Subramaniam, S, Caldwell, LJ, Fitzgerald, D, Harrison, NA, Hong, S et al.. Research priorities for neuroimmunology: identifying the key research questions to be addressed by 2030. Wellcome Open Res. 2021;6 :194. doi: 10.12688/wellcomeopenres.16997.1. PubMed PMID:34778569 PubMed Central PMC8558843.
Search PubMed

Affiliations & Other Activities

  • Professor, Department of Immunology, University of Toronto